{
    "answer": "Cosentyx's net sales in the immunology segment for the full year 2024 were USD 1,596 million, representing a growth of 22% on a reported basis and 24% on a constant currency basis. Full-year 2023 immunology segment sales and changes are not provided in the supplementary financial data reports.",
    "ground_truth": "$6,141,000,000; 23% increase (reported); 25% increase (constant currency)",
    "rewards": [
        0,
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 4,
    "search count": 3,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        930,
        3074,
        4416,
        5005
    ]
}